Every 10-Q that Innospec Inc. (IOSP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow IOSP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IOSP filings page.
Innospec Inc. reported higher results for the quarter ended June 30, 2026. Net sales rose to $491.4 million from $439.7 million, and net income attributable to Innospec increased to $30.8 million, with diluted EPS of $1.25 versus $0.94 a year earlier.
All three segments grew sales: Performance Chemicals to $190.3 million, Fuel Specialties to $185.7 million, and Oilfield Services to $115.4 million, with Oilfield Services showing the strongest gross margin improvement. Six‑month operating cash flow declined to $24.8 million from $38.8 million, mainly from higher receivables and inventory. Cash and cash equivalents were $250.2 million, and the company had no borrowings under its $250.0 million multicurrency revolving credit facility. Innospec paid $22.7 million in dividends, repurchased $13.5 million of stock, carries plant closure provisions of $64.7 million, and continues to pursue civil and criminal claims related to a prior inventory misappropriation in Brazil with no significant new developments.
Innospec Inc. (IOSP) reported third-quarter 2025 results. Net sales were $441.9 million versus $443.4 million a year ago. Operating income fell to $5.9 million from $45.6 million, and net income was $12.9 million, or $0.52 diluted EPS, compared with $33.4 million, or $1.33 diluted EPS.
Segment trends were mixed. Performance Chemicals sales rose 4% to $170.8 million but gross margin declined to 15.1% on pricing erosion and mix. Fuel Specialties grew 4% to $172.0 million with gross margin up to 35.6% on improved mix and disciplined pricing. Oilfield Services declined 13% to $99.1 million, while gross margin improved to 30.0% on mix.
Results included a $22.9 million impairment of property, plant and equipment and a $19.1 million impairment of intangible assets, partly offset by a $17.7 million credit from contingent consideration revaluation. Cash and cash equivalents were $270.8 million with no borrowings on the $250.0 million revolver. Year-to-date operating cash flow was $76.9 million; the company paid dividends of $20.8 million and repurchased $23.9 million of common stock. Shares outstanding were 24,777,582 as of October 31, 2025.
Innospec’s Q2 2025 10-Q shows mixed performance. Net sales rose 1% YoY to $439.7 m, but net income fell 25% to $23.5 m (EPS $0.94). Lower profitability stemmed from a 120 bp drop in aggregate gross margin to 28.0% and a 3% rise in operating expenses; operating income declined 16% to $34.3 m.
Segment results were uneven: Fuel Specialties boosted gross margin 350 bp to 38.1% and operating income 16% to $35.4 m, while Performance Chemicals margin contracted 510 bp and Oilfield Services revenue fell 7%. For the first half, sales slipped 6% to $880.5 m and net income dropped 22% to $56.3 m (diluted EPS $2.24).
Cash from operations shrank to $37.6 m (-56% YoY) as inventories climbed $35.8 m. Nevertheless, cash & equivalents remain solid at $266.6 m; the $250 m revolver is undrawn and the company carries no long-term debt. Equity improved to $1.30 bn on retained earnings and a $57.6 m favorable FX translation adjustment.
Capital deployment included $32.2 m of capex/ERP spend, $20.8 m dividends ($0.84 / share) and $13.3 m share buybacks under a new $50 m program. Plant-closure provisions were raised $4.1 m and FX hedges produced a $6.4 m loss. Management cites softer demand in Oilfield Services and price pressure in Performance Chemicals, but highlights margin gains in Fuel Specialties and low leverage.